---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-039278"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:52:23.156839+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OSR Holdings signs binding term sheet for VXM01 license; up to $815M in milestones

## Summary
- Vaximm grants BCME exclusive worldwide license to develop and commercialize VXM01; OSRH is primary recipient of milestone payments.
- BCME responsible for up to $815M in milestone payments payable to OSRH; OSRH to provide Vaximm $30M development financing facility.
- Related-party transaction as BCME is OSRH's largest shareholder; independent fairness opinion required before definitive agreement.
- OSRH retains option to issue up to $15M of common stock at $1.00 per share to BCME Fund, exercisable at OSRH's discretion after 6 months.
- Royalties from ultimate licensee pass through to OSRH after BCME recovers a negative milestone delta including up to 15% preferred return.

## SEC filing metadata
- accession: 0001213900-26-039278
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000121390026039278/0001213900-26-039278-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000121390026039278/ea0284791-8k_osr.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-039278
- JSON: https://secwatch.observer/filing/0001213900-26-039278.json
- Plain text: https://secwatch.observer/filing/0001213900-26-039278.txt

## Source-grounded claims
- claim_id: 3fd906e9b46feccd4d4eb4d5155fa9f7d2738439
  claim: OSR Holdings, Inc. entered into Binding Term Sheet with BCM Europe AG valued at up to $815.0 million in milestone payments (effective 2026-03-27).
  evidence_excerpt: On March 27, 2026, OSR Holdings, Inc. (the “Company” or “OSRH”), together with its wholly-owned subsidiary Vaximm AG (“Vaximm”), entered into a Binding Term Sheet (the “Term Sheet”) with BCM Europe AG (“BCME”) relating to a revised global exclusive license arrangement for VXM01.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840425/000121390026039278/0001213900-26-039278-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.